Vandenplas Michel L, Moore James N, Barton Michelle H, Roussel Allen J, Cohen Noah D
Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Am J Vet Res. 2005 Sep;66(9):1509-16. doi: 10.2460/ajvr.2005.66.1509.
To determine concentrations of 2 acute-phase proteins (serum amyloid A [SAA] and lipopolysaccharide-binding protein [LBP]) in serum samples obtained from horses with colic and identify relationships among these acute-phase proteins and clinical data.
765 horses with naturally developing gastrointestinal tract diseases characterized by colic (ie, clinical signs indicative of abdominal pain) and 79 healthy control horses; all horses were examined at 2 university teaching hospitals.
Serum concentrations of SAA and LBP were determined by immunoturbidometric and dot-blot assays, respectively.
SAA and LBP concentrations were determined for 718 and 765 horses with colic, respectively. Concentrations of SAA were significantly higher in nonsurvivors than in survivors, and horses with enteritis or colitis and conditions characterized by chronic inflammation (eg, abdominal abscesses, peritonitis, or rectal tears) had SAA concentrations significantly greater than those for horses with other conditions. Serum concentrations of LBP did not correlate with outcome, disease process, or portion of the gastrointestinal tract affected.
Circulating concentrations of SAA were significantly higher at admission in horses with colic attributable to conditions having a primary inflammatory cause (eg, enteritis, colitis, peritonitis, or abdominal abscesses) and were higher in horses that failed to survive the episode of colic, compared with concentrations in horses that survived. Serum concentrations of LBP did not correlate with survival. Analysis of these findings suggests that evaluation of SAA concentrations may be of use in identifying horses with colic attributable to diseases that have inflammation as a primary component of pathogenesis.
测定从患急腹症的马匹采集的血清样本中2种急性期蛋白(血清淀粉样蛋白A [SAA] 和脂多糖结合蛋白 [LBP])的浓度,并确定这些急性期蛋白与临床数据之间的关系。
765匹自然发生以急腹症(即提示腹痛的临床体征)为特征的胃肠道疾病的马匹和79匹健康对照马;所有马匹均在2所大学教学医院接受检查。
分别通过免疫比浊法和斑点印迹法测定SAA和LBP的血清浓度。
分别测定了718匹和765匹患急腹症马匹的SAA和LBP浓度。非存活马匹的SAA浓度显著高于存活马匹,患有肠炎或结肠炎以及以慢性炎症为特征的疾病(如腹部脓肿、腹膜炎或直肠撕裂)的马匹的SAA浓度显著高于患有其他疾病的马匹。LBP的血清浓度与结局、疾病进程或受影响的胃肠道部位无关。
因原发性炎症原因(如肠炎、结肠炎、腹膜炎或腹部脓肿)导致急腹症的马匹入院时循环中的SAA浓度显著更高,与急腹症发作后存活的马匹相比,未存活的马匹中SAA浓度更高。LBP的血清浓度与存活率无关。对这些发现的分析表明,评估SAA浓度可能有助于识别因炎症作为发病机制主要组成部分的疾病而患急腹症的马匹。